Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study

PLoS Medicine

Volumn 9, Issue 8, 2012, Pages

  Kranzer, Katharina ^a,b   Lawn, Stephen D ^a,b   Meyer Rath, Gesine ^a,c,d   Vassall, Anna ^a,e   Raditlhalo, Eudoxia ^b   Govindasamy, Darshini ^b   van Schaik, Nienke ^b   Wood, Robin ^b   Bekker, Linda Gail ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL EFFECTIVENESS; CONTACT EXAMINATION; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PATHOGEN LOAD; PREVALENCE; PREVENTIVE HEALTH SERVICE; SCREENING TEST; SENSITIVITY ANALYSIS; SOUTH AFRICA; SPUTUM EXAMINATION; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; CONTACT TRACING; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEASIBILITY STUDIES; FEMALE; GEOGRAPHY; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOBILE HEALTH UNITS; PREVALENCE; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84865565481     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001281     Document Type: Article

References (52)

1. WHO Three I's Meeting (2008) Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/meetingreports/WHO_3Is_meeting_report.pdf. Accessed 31 August 2011.
2. WHO (2010) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/tb/9789241500708/en/index.html. Accessed 20 February 2011.
3. International Union Against Tuberculosis and Lung Disease (2007) Best practice for the care of patients with tuberculosis: a guide for low-income countries. Paris: International Union Against Tuberculosis and Lung Disease. Available: http://www.theunion.org/index.php/en/resources/scientific-publications/tuberculosis/item/104-best-practice-for-the-care-of-patients-with-tuberculosis-a-guide-for-low-income-countries. Accessed 21/9/2011.
4. International Union Against Tuberculosis and Lung Disease (2002) Interventions for TB control and elimination. Paris: International Union Against Tuberculosis and Lung Disease. Available: http://www.tbrieder.org/publications/books_english/interventions.pdf. Accessed 21/9/2011.
5. WHO (2006) Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.371_eng.pdf. Accessed 21/9/2011.
6. Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, et al. (2010) Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 376: 1244-1253.
7. WHO (2011) Scoping meeting for the development of guidelines on screening for active TB. Geneva: World Health Organization. Available: http://www.who.int/tb/TBscreeningmeetingreport2011.pdf. Accessed 31 August 2011.
8. Golub JE, Mohan CI, Comstock GW, Chaisson RE, (2005) Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 9: 1183-1203.
9. Kranzer K, Houben RM, Glynn JR, Bekker LG, Wood R, et al. (2010) Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 10: 93-102.
10. Van Schaik N, Kranzer K, Wood R, Bekker LG, (2010) Earlier HIV diagnosis- are mobile services the answer? S Afr Med J 100: 671-674.
11. Western Cape Department of Health.The Western Cape Antiretroviral Programme (2006) Cape Town: Provincial Government of the Western Cape: Western Cape Department of Health. Available: http://web.uct.ac.za/depts/epi/artrollout/. Accessed 2 February 2011.
12. WHO (2000) Costing guidelines for HIV/AIDS prevention strategies. UNAIDS Best Practice Collection- Key Materials. Geneva: UNAIDS. Available: http://www.unaids.org/html/pub/publications/irc-pub05/jc412-costguidel_en_pdf.pdf. Accessed 14 September 2011.
13. Drummond MF, O'Brien B, Stoddart GL, (1997) Methods for the economic evaluation of health care programmes. New York: Oxford University Press.
14. Kumaranayake L, (2000) The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 15: 230-234.
15. International Monentary Fund. Available: http://www.imf.org. Accessed 15 Augut 2011.
16. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, et al. (2003) Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 7: S56-62.
17. University of the Witswatersrand and Centre for Global Health and Development, Boston University (20110 The cost of the Xpert diagnostic algorithm for TB. Results of the national TB cost model (NTCM) 2011/12 to 2016/17. Witswatersrand and Boston: University of the Witswatersrand and Centre for Global Health and Development, Boston University.
18. Final evaluation report enhanced tuberculosis adherence programm. Cape Town. Available: http://www.mrc.ac.za/healthsystems/finalr.pdf. Accessed 1 September 2011.
19. Storla DG, Yimer S, Bjune GA, (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.
20. Munseri PJ, Bakari M, Pallangyo K, Sandstrom E, (2010) Tuberculosis in HIV voluntary counselling and testing centres in Dar es Salaam, Tanzania. Scand J Infect Dis 42: 767-774.
21. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, et al. (2009) Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23: 1875-1880.
22. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, et al. (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIf assay: a prospective study. PLoS Med 8: e1001067 doi:10.1371/journal.pmed.1001067.
23. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, et al. (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51: 823-829.
24. Cassels A, Heineman E, LeClerq S, Gurung PK, Rahut CB, (1982) Tuberculosis case-finding in Eastern Nepal. Tubercle 63: 175-185.
25. den Boon S, Verver S, Lombard CJ, Bateman ED, Irusen EM, et al. (2008) Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding. Epidemiol Infect 136: 1342-1349.
26. Santha T, Renu G, Frieden TR, Subramani R, Gopi PG, et al. (2003) Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. Int J Tuberc Lung Dis 7: 258-265.
27. Gupta A, Nayak U, Ram M, Bhosale R, Patil S, et al. (2007) Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis 45: 241-249.
28. Harper I, Fryatt R, White A, (1996) Tuberculosis case finding in remote mountainous areas-are microscopy camps of any value? Experience from Nepal. Tuber Lung Dis 77: 384-388.
29. Botha E, den Boon S, Lawrence KA, Reuter H, Verver S, et al. (2008) From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int J Tuberc Lung Dis 12: 936-941.
30. Botha E, Den Boon S, Verver S, Dunbar R, Lawrence KA, et al. (2008) Initial default from tuberculosis treatment: how often does it happen and what are the reasons? Int J Tuberc Lung Dis 12: 820-823.
31. Edginton ME, Wong ML, Phofa R, Mahlaba D, Hodkinson HJ, (2005) Tuberculosis at Chris Hani Baragwanath Hospital: numbers of patients diagnosed and outcomes of referrals to district clinics. Int J Tuberc Lung Dis 9: 398-402.
32. Dunbar R, Lawrence K, Verver S, Enarson DA, Lombard C, et al. (2011) Accuracy and completeness of recording of confirmed tuberculosis in two South African communities. Int J Tuberc Lung Dis 15: 337-343.
33. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505.
34. Thornton R, (2005) The impact of incentives on learning HIV status: evidence from a field experiment. Cambridge (Massachusetts): Havard University.
35. Hausler HP, Sinanovic E, Kumaranayake L, Naidoo P, Schoeman H, et al. (2006) Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa. Bull World Health Organ 84: 528-536.
36. Sutton BS, Arias MS, Chheng P, Eang MT, Kimerling ME, (2009) The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. Int J Tuberc Lung Dis 13: 713-718.
37. Dowdy DW, O'Brien MA, Bishai D, (2008) Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1021-1029.
38. Shillcutt SD, Walker DG, Goodman CA, Mills AJ, (2009) Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics 27: 903-917.
39. World Bank (2012) GDP per capita (current US$). Available: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 2 May 2012.
40. Ayles H, Schaap A, Nota A, Sismanidis C, Tembwe R, et al. (2009) Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One 4: e5602 doi:10.1371/journal.pone.0005602.
41. Middelkoop K, Bekker LG, Myer L, Whitelaw A, Grant A, et al. (2010) Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 182: 1080-1085.
42. Corbett EL, Bandason T, Cheung YB, Makamure B, Dauya E, et al. (2009) Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis 13: 1231-1237.
43. Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, et al. (2007) Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175: 87-93.
44. Demissie M, Zenebere B, Berhane Y, Lindtjorn B, (2002) A rapid survey to determine the prevalence of smear-positive tuberculosis in Addis Ababa. Int J Tuberc Lung Dis 6: 580-584.
45. Sekandi JN, Neuhauser D, Smyth K, Whalen CC, (2009) Active case finding of undetected tuberculosis among chronic coughers in a slum setting in Kampala, Uganda. Int J Tuberc Lung Dis 13: 508-513.
46. Guwatudde D, Zalwango S, Kamya MR, Debanne SM, Diaz MI, et al. (2003) Burden of tuberculosis in Kampala, Uganda. Bull World Health Organ 81: 799-805.
47. den Boon S, van Lill SW, Borgdorff MW, Enarson DA, Verver S, et al. (2007) High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa. Emerg Infect Dis 13: 1189-1194.
48. Pronyk PM, Joshi B, Hargreaves JR, Madonsela T, Collinson MA, et al. (2001) Active case finding: understanding the burden of tuberculosis in rural South Africa. Int J Tuberc Lung Dis 5: 611-618.
49. Kranzer K, Olson L, van Schaik N, Raditlhalo E, Hudson E, et al. (2011) Quality of induced sputum using a human-powered nebuliser in a mobile human immunodeficiency virus testing service in South Africa. Int J Tuberc Lung Dis 15: 1077-1081.
50. WHO (2011) Global tuberculosis control. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf.
51. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, et al. (2010) The HIV-associated tuberculosis epidemic-when will we act? Lancet 375: 1906-1919.
52. van't Hoog AH, Laserson KF, Githui WA, Meme HK, Agaya JA, et al. (2011) High prevalence of pulmonary tuberculosis and inadequate case finding in rural western Kenya. Am J Respir Crit Care Med 183: 1245-1253.